A series of penicillins characterized by the presence of a sulfoamino or a modified sulfoamino group in the side chain was subjected to in vitro antimicrobial screening tests. Although the most potent members of the series were less active than benzylpenicillin against gram-positive bacteria and comparably active against most gram-negative bacteria, they were, on the average, 8 to 16 times more effective against strains of Pseudomonas aeruginosa. In other comparative laboratory tests against P. aeruginosa, these compounds were about as active as carbenicillin and four to eight times more active than ampicillin. An examination of structure-activity relationships indicated that maximal potency was obtained with penicillins having an a-(aromatic or heteroaromatic)-a-sulfoaminoacetamido side chain. The compound with an ca-phenyl group was comparable in activity to those having an a-(2-or 3-thienyl) group, whereas any modification in position or structure of the a-sulfoamino group reduced activity. Results of studies with a cell-free P. aeruginosa f-lactamase suggest that the marked inhibitory effects of a-sulfoamino penicillins for P. aeruginosa can be attributed, at least in part, to their high degree of resistance to this enzyme. Some derivatives, however, had weak antipseudomonal activity, despite possessing a high degree of 03-lactamase resistance.
A series of penicillins characterized by the presence of a sulfoamino or a modified sulfoamino group in the side chain was subjected to in vitro antimicrobial screening tests. Although the most potent members of the series were less active than benzylpenicillin against gram-positive bacteria and comparably active against most gram-negative bacteria, they were, on the average, 8 to 16 times more effective against strains of Pseudomonas aeruginosa. In other comparative laboratory tests against P. aeruginosa, these compounds were about as active as carbenicillin and four to eight times more active than ampicillin. An examination of structure-activity relationships indicated that maximal potency was obtained with penicillins having an a-(aromatic or heteroaromatic)-a-sulfoaminoacetamido side chain. The compound with an ca-phenyl group was comparable in activity to those having an a-(2-or 3-thienyl) group, whereas any modification in position or structure of the a-sulfoamino group reduced activity. Results of studies with a cell-free P. aeruginosa f-lactamase suggest that the marked inhibitory effects of a-sulfoamino penicillins for P. aeruginosa can be attributed, at least in part, to their high degree of resistance to this enzyme. Some derivatives, however, had weak antipseudomonal activity, despite possessing a high degree of 03-lactamase resistance.
Pseudomonas aeruginosa infections of man, whether systemic or localized, have been found to be extremely refractory to chemotherapy (6, 12) . Polymyxins (both B and E) and the aminoglycosidic antibiotic, gentamicin, have been successfully used for treatment of some patients, but have limited usefulness because their ranges between effective and toxic doses are very narrow (5, 9, 10, 11) . Penicillins, which produce virtually no toxic effects in man, have uniformly been found to be devoid of significant inhibitory effects against this organism. Recently, however, a new semisynthetic penicillin, carbenicillin (disodium a-carboxybenzylpenicillin), was found quite active against P. aeruginosa strains in vitro (1, 2, 12) . Furthermore, clinical efficacy has been shown for this compound in patients with Pseudomonasinfected burns as well as respiratory, urinary tract, and generalized Pseudomonas infections (3, 8, 14 Patent 3, 381, 001) . Those having an a-aromatic or a-heteroaromatic group and a substituted a-amino group were prepared directly from the corresponding a-amino-penicillin. In all cases except one, the compounds had the same configuration as that of ampicillin, which was derived from R-phenylglycine [nomenclature of Cahn (4) ]. The other penicillins were prepared by acylation of 6-aminopenicillanic acid with racemic mixtures of the appropriate amino acid chlorides. The purity of each of the above-mentioned penicillins was estimated to be at least 85%.
Minimal inhibitory concentration (MIC) values were determined by agar-dilution tests. In this procedure, antibiotics were incorporated into Nutrient Agar (Difco) or Trypticase Soy Agar (BBL) with 2% defibrinated sheep blood. After plates solidified, the surface was inoculated with undiluted to 100-folddiluted overnight broth cultures by means of the Steers multiple inoculator apparatus (13) . The end point, which was determined after overnight incubation at 37 C, was the lowest concentration that suppressed visible growth.
Resistance of the penicillins to P. aeruginosa ,3-lactamase was determined by incubating the test compound with a cell-free extract of the organism and assaying the residual bioactivity at various time periods.
The crude J8-lactamase was prepared as follows. P. aeruginosa A9843 was grown overnight at 37 C in Heart Infusion Broth (Difco) with BL-P 1462 (asulfoaminobenzylpenicillin) added at 50 pig/ml as an enzyme inducer. Cells were harvested, washed twice in physiological saline, resuspended in saline at 100th the original volume, and then disrupted by subjecting 15-ml samples to a Raytheon sonic oscillator (Raytheon Mfg. Co 
RESULTS AND DISCUSSION
In routine antimicrobial screening tests, it was noted that a new penicillin, BL-P 1462 (a-sulfoaminobenzylpenicillin), was unusually active against P. aeruginosa. A comparison of the antibacterial spectrum of this compound with that of penicillin G (benzylpenicillin) is presented in Table 1 .
With the exception of penicillinase-producing (penase +) staphylococci, penicillin G is 10 to 20 times more active than BL-P 1462 against grampositive bacteria. The superior activity of the latter compound against penase + staphylococci can undoubtedly be attributed to the fact that its degree of resistance to staphylococcal penicillinase is at least three times greater than that of penicillin G (K. E. Price, unpublished data).
In the case of gram-negative bacilli, however, enterobacteria strains were equally susceptible to the two compounds, whereas the inhibitory activity of BL-P 1462 against P. aeruginosa strains was up to 17 times greater than that of penicillin G.
Since the a-sulfoamino group of BL-P 1462 appeared to be responsible for its effect against P. aeruginosa, additional penicillins having this group in their side chain were synthesized and tested. Table 2 shows the MIC values of various compounds for P. aeruginosa A9843 and Staphylococcus aureus A9537 as well as the ratio of the two MIC values. Also shown for some of the penicillins is their degree of resistance, relative to ampicillin, to hydrolysis by a crude j-lactamase from P. aeruginosa A9843.
BL-P 1462, the first compound in Table 2 , had an MIC for P. aeruginosa of 32 and thus, was approximately 25 times less active against this organism than the S. aureus strain. Its resistance to the j3-lactamase of P. aeruginosa A9843 was 10-fold greater than that of ampicillin. Similar MIC values were found for the second compound, which differs from BL-P 1462 only in that one of the oxygens in the 3-carboxyl group has been replaced by sulfur (see R2 in Table 2 ). Compound 3, Table 2 ). This penicillin, which had an RC value of only 0.8, was found to have no antipseudomonal activity (MIC = > 500), despite the fact that its MIC for S. aureus was 0.32 ,4g/ml.
APPL. MICROBIOL.
Since the results shown in Table 2 suggest that an antipseudomonal effect is obtained only when the penicillin side chain has a sulfoamino group as one of the substituents on a disubstituted a-carbon, a comparison of the activity of several a-sulfoamino derivatives which have a second substituent present on the a-carbon was made ( Table 3) .
The first two compounds are diastereoisomers of a-phenyl-a-sulfoaminomethylpenicillin. Configuration does appear to have an effect on antibacterial activity, since the "S" form is only about one-fourth as inhibitory for P. aeruginosa as the "R" form. The fact that the ratios of the Pseudomonas to Staphylococcus MIC values are the Introduction of an iodo radical into the paraposition of the phenyl ring of R-(a-phenyl-asulfoaminomethyl)penicillin (compound 3) resulted in decreased antipseudomonal but increased antistaphylococcal activity. The degree of resistance of the penicillin to P. aeruginosa 3-lactamase was not determined.
The next two compounds (4 and 5) are asulfoamino-a-(2-or 3-thienyl) methylpenicillins. Their antibacterial spectra and degree ofresistance to Pseudomonas /3-lactamase are similar to those of compound 1 (BL-P 1462). The potency of the compounds also appears comparable to that of BL-P 1462.
The final compound, a-methyl-a-sulfoaminomethylpenicillin, had very poor antipseudomonal activity. Thus, cyclic substituents in a-substituted a-sulfoaminomethylpenicillins appear to confer greater Pseudomonas-inhibitory effects than shortchain aliphatic groups. Cyclic substituents are not required, however, for preservation of the antistaphylococcal activity of the compound or resistance to the 3-lactamase preparation.
Since an a-phenyl substituent appears to be associated with good anti-Pseudomonas activity, a series of derivatives containing this group (benzylpenicillins) were substituted at the acarbon with modified sulfoamino groups in an effort to further increase activity against this organism (Table 4) .
Compound 2, where an N-methyl group has been introduced into the a-sulfoamino moiety, has essentially the same spectrum (Pseudomonas to Staphylococcus MIC ratio) as compound 1 (BL-P 1462). There is an indication, however, that relative to BL-P 1462, the antibacterial potency of the penicillin is somewhat less, although its resistance to the 3-lactamase preparation is significantly greater.
Incorporation of a propyl group into the asubstituent so as to give a-(3-sulfopropylamino)-benzylpenicillin results in a compound with little antipseudomonal, but high antistaphylococcal, activity. The resistance of the compound to (3-lactamase was not determined.
Although the last two derivatives both have potent antistaphylococcal activity, only compound 5, which is a-(N,N-dimethylsulfamido)-benzylpenicillin, is inhibitory for P. aeruginosa. This compound was less active than BL-P 1462 (compound 1) but comparably resistant to the pseudomonal (3-lactamase. The (3-lactamase resistance of a-(methanesulfonamido)benzylpenicillin (compound 4) was not determined.
On the basis of the data shown in Tables 1 to 4 , it appears that maximal antipseudomonal activity is obtained with penicillins having an a-(unsubstituted aromatic or heteroaromatic)-a-sulfoaminoacetamido side chain. The compound with the a-phenyl group is comparable in activity to those with an a-(2-or 3-thienyl) radical, whereas / any modification in position or structure of the cL-sulfoamino group appears to be detrimental to activity. The structural requirements for resistance to Pseudomonas i3-lactamase seem much less rigid, although the mere presence of a sulfoamino group in the side chain is not sufficient, as attested to by the relatively high susceptibility of p-sulfoaminobenzylpenicillin to enzymatic hydrolysis. Finally, antistaphylococcal activity was noticeably poorer for those penicillins lacking an aromatic group in the side chain.
If one assumes a relationship between antipseudomonal activity and 3-lactamase resistance, the above findings give rise to two important questions. First, what is responsible for the variation in antipseudomonal activity possessed by this large group of closely related, enzyme-resistant and antimicrobially potent compounds and, second, how can simple a-substituents protect the 13-lactam ring from enzymatic hydrolysis? Re- garding the first question, it seems probable that variations in activity can be attributed to the relative ability of the compounds to reach the site of action or their degree of affinity for the enzymes involved in cross-linking cell wall peptidoglycan strands, or both. As far as the second question is concerned, it is possible that the negative charge on the a-or 3-carbon substituent prevents enzy- matic hydrolysis through electrostatic repulsion or, alternately, the substituent may hinder enzyme attachment in essentially the same way that the bulky methoxy groups of methicillin hinder attachment to staphylococcal enzymes. Such blocking could occur with these a-substituents because, although small, they are quite polar and thus are surrounded by a relatively stable and quite large hydration sphere. Carbenicillin, which is extremely resistant to the penicillinase of P. aeruginosa strain A9843 (K. E. Price, unpublished data), also has a highly polar group (-COONa) on the a-carbon.
BL-P 1462, one of the most active members of this group of penicillins, was evaluated against a number of P. aeruginosa strains in comparative in vitro tests with ampicillin and carbenicillin (Fig.  1) .
Ampicillin failed to suppress growth of any strain at 250 ,g/ml, whereas BL-P 1462 and carbenicillin each inhibited more than 50% of the strains at a concentration of 63 ug/ml and at least 80% at 125 ,ug/ml. On the basis of these results, there appears to be little difference in the antipseudomonal activities of BL-P 1462 and carbenicillin.
In view of this finding and because BL-P 1462 has proven to be efficacious in experimental P. aeruginosa infections, whether systemic in the mouse or localized in the urinary tract of rats (K. E. Price, unpublished data), it will be subjected to thorough pharmacological and toxicological examination to determine its suitability for clinical investigation.
